Krajina: Kanada
Jazyk: angličtina
Zdroj: Health Canada
METHACHOLINE CHLORIDE
PANDA PHARMACEUTICALS INC.
V04CX
OTHER DIAGNOSTIC AGENTS
1600MG
POWDER FOR SOLUTION
METHACHOLINE CHLORIDE 1600MG
INHALATION
50ML
Prescription
OTHER DIAGNOSTIC AGENTS
Active ingredient group (AIG) number: 0136042007; AHFS:
APPROVED
2017-09-15
_Page 1 of 30 _ PRODUCT MONOGRAPH PR METHACHOLINE CHLORIDE, USP Powder for inhalation solution 100 mg, 160 mg, 320 mg, 1280 mg and 1600 mg Cholinergic / Diagnostic Aid (Bronchial Asthma) Date of Preparation: September 14, 2017 PANDA Pharmaceuticals. 35 Nixon Road Caledon, Ontario L7E 1K1 Control #204408 _Page 2 of 30 _ TABLE OF CONTENTS PART I : HEALTH PROFESSIONAL INFORMATION ............................................................................. 3 SUMMARY PRODUCT INFORMATION ................................................................................................... 3 INDICATIONS AND CLINICAL USE......................................................................................................... 3 CONTRAINDICATIONS .............................................................................................................................. 4 WARNINGS AND PRECAUTIONS ............................................................................................................ 4 ADVERSE REACTIONS .............................................................................................................................. 7 DRUG INTERACTIONS ............................................................................................................................... 7 DOSAGE AND ADMINISTRATION ........................................................................................................... 8 OVERDOSAGE ........................................................................................................................................... 20 ACTION AND CLINICAL PHARMACOLOGY ....................................................................................... 20 STORAGE AND STABILITY .................................................................................................................... 21 SPECIAL HANDLING INSTRUCTIONS .................................................................................................. 21 DOSAGE FORMS, COMPOSITION AND PACKAGING ................ Prečítajte si celý dokument